ctrl K

Price Alert

Mersana Therapeutics Inc. (MRSN)

NASDAQ: MRSN · Real-Time Price · USD

7.14

-0.28 (-3.77%)

At close: Aug 15, 2025, 3:59 PM

7.44

4.20%

After-hours: Aug 15, 2025, 06:16 PM EDT

Mersana Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	107.75M	174.56M	128.88M	177.95M
Short-Term Investments	26.87M	34.52M	151.83M	n/a
Long-Term Investments	n/a	n/a	478K	478K
Other Long-Term Assets	978K	478K	661K	1.88M
Receivables	n/a	n/a	30M	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	2.28M	4.97M	8.51M	10.95M
Total Current Assets	136.9M	214.06M	319.22M	188.9M
Property-Plant & Equipment	6.78M	11.53M	14.46M	14.86M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.76M	12M	15.12M	17.21M
Total Assets	144.66M	226.06M	334.34M	206.11M
Account Payables	4.33M	7.32M	13.95M	12.32M
Deferred Revenue	22.17M	28.15M	30.61M	3.94M
Short-Term Debt	12.5M	2.08M	240K	239K
Other Current Liabilities	12.26M	13.88M	32.62M	21.64M
Total Current Liabilities	62.46M	63.64M	91.53M	47.52M
Long-Term Debt	10.95M	23.15M	24.93M	24.63M
Other Long-Term Liabilities	8K	1K	203K	974K
Total Long-Term Liabilities	91.71M	125.52M	150.75M	36.85M
Total Liabilities	154.17M	189.16M	242.28M	84.37M
Total Debt	28.6M	33.83M	36.3M	38.18M
Common Stock	12K	12K	11K	7K
Retained Earnings	-895.55M	-826.36M	-654.69M	-450.48M
Comprehensive Income	10K	11K	-152K	n/a
Shareholders Equity	-9.51M	36.9M	92.06M	121.74M
Total Investments	26.87M	34.52M	151.83M	478K